---
title: "NMRK: Record Q2 revenue and robust growth support a strong 2026 outlook and cash flow generation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294216218.md"
description: "Record Q2 revenues and double-digit growth across all major business lines drove strong year-to-date results, with Adjusted EPS up 37% and Adjusted EBITDA up 28%. The outlook for 2026 remains robust, targeting continued double-digit growth and significant cash flow generation.Original document: Newmark Group, Inc. [NMRK] SEC 8-K Current Report — Jul. 29 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-29T13:28:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294216218.md)
  - [en](https://longbridge.com/en/news/294216218.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294216218.md)
generator: "portal-rs"
---

# NMRK: Record Q2 revenue and robust growth support a strong 2026 outlook and cash flow generation

Record Q2 revenues and double-digit growth across all major business lines drove strong year-to-date results, with Adjusted EPS up 37% and Adjusted EBITDA up 28%. The outlook for 2026 remains robust, targeting continued double-digit growth and significant cash flow generation.

Original document: Newmark Group, Inc. \[NMRK\] SEC 8-K Current Report — Jul. 29 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [NMRK.US](https://longbridge.com/en/quote/NMRK.US.md)

## Related News & Research

- [Newmark Group (NMRK) CEO Transition Tests the Firm’s Expansion and Recurring-Revenue Strategy](https://longbridge.com/en/news/296223336.md)
- [Most of Gen Z is now afraid AI will steal their jobs.](https://longbridge.com/en/news/296492576.md)
- [Petrolia Noco announces availability of Q2 2026 report](https://longbridge.com/en/news/296871879.md)
- [Upwork (UPWK) Q2 2026 Earnings Call Transcript](https://longbridge.com/en/news/296158870.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**